Verification evidence is still being completed.
PDF / print export
Orion Corporation
Espoo, Finland
- Verified lead
- Liisa Hurme
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- President and CEO
- 2026 technical specialization
- Pharmaceutical R&D
- Review cycle
- May 2026
- Full address
- Professional N/A
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Orion corporate governance page confirming Liisa Hurme as President and CEO.
- Editorial note
- Orion's Espoo governance surface remains current and keeps Liisa Hurme in the verified lead position for the Finnish anchor.
Pharmaceutical R&D
GMP Certified, ISO 14001
Orion's Espoo governance surface remains current and keeps Liisa Hurme in the verified lead position for the Finnish anchor.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Espoo, Finland
Orion Corporation
Pharmaceutical R&D · Global Market
Orion's Espoo governance surface remains current and keeps Liisa Hurme in the verified lead position for the Finnish anchor.
- Lead
- Liisa Hurme (verified ↗)
- Address
- Not yet on record (source ↗)
- Compliance
- GMP Certified · ISO 14001
- Last reviewed
- 14 Mar 2026 (3mo ago)
- Scale
- Global Market
- Capabilities
- API Production · Drug Product Formulation · Neuroscience Research
- Founded
- 1917
- Headcount
- 1001-5000
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Liisa Hurme
President and CEO
Full addressProfessional N/A
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Orion locations page listing Espoo and other Finnish operating sites.
Open sourceGlobal Market
Espoo, Finland. Pharmaceutical R&D. Review completed on 14 Mar 2026.
Fimea
GMP Certified, ISO 14001
Pharmaceutical R&D
Orion's Espoo governance surface remains current and keeps Liisa Hurme in the verified lead position for the Finnish anchor.
Editorial note
Orion's Espoo governance surface remains current and keeps Liisa Hurme in the verified lead position for the Finnish anchor.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
API Production
Drug Product Formulation
Neuroscience Research
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Industrial Synthesis Skids
Fill-Finish Lines
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- VERIFIED ACTIVE 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Trust review remains in progress.
FAQ
Frequently asked questions
- Where is Orion Corporation located?
- Orion Corporation is based in Espoo, Finland.
- Who runs Orion Corporation?
- Orion Corporation is led by Liisa Hurme, President and CEO. Verified 14 Mar 2026.
- What certifications does Orion Corporation hold?
- Orion Corporation is documented under GMP Certified, ISO 14001.
- What does Orion Corporation do?
- Orion's Espoo governance surface remains current and keeps Liisa Hurme in the verified lead position for the Finnish anchor. Core capabilities: API Production, Drug Product Formulation, Neuroscience Research.
Editorial context
Related technical briefs
Briefs that name Espoo as a covered market or city.